Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
3(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 33 (100.0%)

Trials by Status

completed250%
not_yet_recruiting125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
completed

The Construction and Validation of a Risk Prediction Model for Perioperative Hypoglycemia in Digestive Endoscopy

NCT07132476
completedphase_3

Treatment Protocol for Non-Metastatic Unilateral Retinoblastoma

NCT03475121
not_yet_recruitingphase_3

Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)

NCT06323148
recruitingphase_3

Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy

NCT04989647

Clinical Trials (4)

Showing 4 of 4 trials
NCT07132476

The Construction and Validation of a Risk Prediction Model for Perioperative Hypoglycemia in Digestive Endoscopy

Completed
NCT03475121Phase 3

Treatment Protocol for Non-Metastatic Unilateral Retinoblastoma

Completed
NCT06323148Phase 3

Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)

Not Yet Recruiting
NCT04989647Phase 3

Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy

Recruiting

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4